Cargando…
Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors
Peptides that are composed of dextrorotary (d)-amino acids have gained increasing attention as a potential therapeutic class. However, our understanding of the in vivo fate of d-peptides is limited. This highlights the need for whole-body, quantitative tracking of d-peptides to better understand how...
Autores principales: | Hu, Kuan, Wu, Wenyu, Xie, Lin, Geng, Hao, Zhang, Yiding, Hanyu, Masayuki, Zhang, Lulu, Liu, Yinghuan, Nagatsu, Kotaro, Suzuki, Hisashi, Guo, Jialin, Wu, Yundong, Li, Zigang, Wang, Feng, Zhang, Mingrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069398/ https://www.ncbi.nlm.nih.gov/pubmed/35530129 http://dx.doi.org/10.1016/j.apsb.2021.09.016 |
Ejemplares similares
-
Harnessing the PD-L1 interface peptide for positron emission tomography imaging of the PD-1 immune checkpoint
por: Hu, Kuan, et al.
Publicado: (2020) -
Development of a Stable Peptide-Based PET Tracer for
Detecting CD133-Expressing Cancer Cells
por: Hu, Kuan, et al.
Publicado: (2021) -
Radiotheranostic Agents in Hematological Malignancies
por: Caers, Jo, et al.
Publicado: (2022) -
Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics
por: Silva, Francisco, et al.
Publicado: (2020) -
Radiotheranostics Practice in India- Advancing to Precision Oncology
por: Kumar, Rakesh, et al.
Publicado: (2022)